104 related articles for article (PubMed ID: 14560555)
21. [Vaccination in adults].
Caillard JF
Rev Prat; 1995 Jun; 45(12):1508-11. PubMed ID: 7660005
[TBL] [Abstract][Full Text] [Related]
22. Successes and remaining challenges after 10 years of varicella vaccination in the USA.
Davis MM
Expert Rev Vaccines; 2006 Apr; 5(2):295-302. PubMed ID: 16608428
[TBL] [Abstract][Full Text] [Related]
23. Using computer simulations to compare pertussis vaccination strategies in Australia.
Hethcote HW; Horby P; McIntyre P
Vaccine; 2004 Jun; 22(17-18):2181-91. PubMed ID: 15149775
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis A vaccines and the elderly.
Genton B; D'Acremont V; Furrer HJ; Hatz C; Louis Loutan
Travel Med Infect Dis; 2006 Dec; 4(6):303-12. PubMed ID: 17098625
[TBL] [Abstract][Full Text] [Related]
25. Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands.
de Greeff SC; Mooi FR; Schellekens JF; de Melker HE
Pediatr Infect Dis J; 2008 Mar; 27(3):218-23. PubMed ID: 18277916
[TBL] [Abstract][Full Text] [Related]
26. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
America Academy of Pediatrics Commitee on Infectious Diseases
Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
[TBL] [Abstract][Full Text] [Related]
27. Vaccinating adolescents against meningococcal disease in Canada: a cost-effectiveness analysis.
De Wals P; Coudeville L; Trottier P; Chevat C; Erickson LJ; Nguyen VH
Vaccine; 2007 Jul; 25(29):5433-40. PubMed ID: 17560695
[TBL] [Abstract][Full Text] [Related]
28. Chickenpox vaccines: new drugs. A favourable risk-benefit balance in some situations.
Prescrire Int; 2005 Jun; 14(77):85-91. PubMed ID: 15977369
[TBL] [Abstract][Full Text] [Related]
29. How do physicians immunize their own children? Differences among pediatricians and nonpediatricians.
Posfay-Barbe KM; Heininger U; Aebi C; Desgrandchamps D; Vaudaux B; Siegrist CA
Pediatrics; 2005 Nov; 116(5):e623-33. PubMed ID: 16263976
[TBL] [Abstract][Full Text] [Related]
30. Vaccination coverage rates in eleven European countries during two consecutive influenza seasons.
Blank PR; Schwenkglenks M; Szucs TD
J Infect; 2009 Jun; 58(6):446-58. PubMed ID: 19446340
[TBL] [Abstract][Full Text] [Related]
31. Influenza vaccination coverage rates in Germany a population-based cross-sectional analysis of the seasons 2002/2003 and 2003/2004.
Müller D; Wutzler P; Szucs TD
Med Klin (Munich); 2005 Jan; 100(1):6-13. PubMed ID: 15654537
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis B vaccination status among healthy adults in Germany.
Ringwald J; Mertz I; Zimmermann R; Weisbach V; Rabe C; Strasser E; Seyboth S; Eckstein R
Health Policy; 2006 Dec; 79(2-3):306-12. PubMed ID: 16516334
[TBL] [Abstract][Full Text] [Related]
33. Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD.
Schembri S; Morant S; Winter JH; MacDonald TM
Thorax; 2009 Jul; 64(7):567-72. PubMed ID: 19321465
[TBL] [Abstract][Full Text] [Related]
34. Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses.
Engler RJ; Nelson MR; Klote MM; VanRaden MJ; Huang CY; Cox NJ; Klimov A; Keitel WA; Nichol KL; Carr WW; Treanor JJ;
Arch Intern Med; 2008 Dec; 168(22):2405-14. PubMed ID: 19064822
[TBL] [Abstract][Full Text] [Related]
35. Survey of the level of anti-HBs antibody titer in vaccinated Iranian general dentists.
Alavian SM; Izadi M; Zare AA; Lankarani MM; Assari S; Vardi MM
Spec Care Dentist; 2008; 28(6):265-70. PubMed ID: 19068068
[TBL] [Abstract][Full Text] [Related]
36. Feasibility of influenza immunization for inner-city children aged 6 to 23 months.
Zimmerman RK; Hoberman A; Nowalk MP; Lin CJ; Greenberg DP; Weinberg ST; Bemm CW; Block B
Am J Prev Med; 2004 Dec; 27(5):397-403. PubMed ID: 15556740
[TBL] [Abstract][Full Text] [Related]
37. Immunoprophylactic effects of the anti-leprosy Mw vaccine in household contacts of leprosy patients: clinical field trials with a follow up of 8-10 years.
Sharma P; Mukherjee R; Talwar GP; Sarathchandra KG; Walia R; Parida SK; Pandey RM; Rani R; Kar H; Mukherjee A; Katoch K; Benara SK; Singh T; Singh P
Lepr Rev; 2005 Jun; 76(2):127-43. PubMed ID: 16038246
[TBL] [Abstract][Full Text] [Related]
38. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors.
Lu PJ; Euler GL; Jumaan AO; Harpaz R
Vaccine; 2009 Feb; 27(6):882-7. PubMed ID: 19071175
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and factors associated with self-reported vaccination rates among US adults at high risk of vaccine-preventable hepatitis.
Chen H; Cantrell CR
Curr Med Res Opin; 2006 Dec; 22(12):2489-96. PubMed ID: 17257463
[TBL] [Abstract][Full Text] [Related]
40. [Prophylactic influenza vaccination: what is the situation in Germany?].
Wutzler P
Dtsch Med Wochenschr; 2006 Mar; 131(9):453-7. PubMed ID: 16493571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
